...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Treatment of malignant primary vasodepressive neurocardiogenic syncope with a rate responsive pacemaker driven by heart contractility.
【24h】

Treatment of malignant primary vasodepressive neurocardiogenic syncope with a rate responsive pacemaker driven by heart contractility.

机译:用心脏收缩力驱动的起搏器对恶性原发性血管舒缩性神经源性晕厥进行治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

In a 41-year-old man suffering from frequent syncope, the tilt test reproducibly induced a primary vasodepressive neurocardiogenic syncope. Pharmacotherapy either failed to prevent the syncope induced at the tilt test or was poorly tolerated. In the minutes preceding the syncope, a dramatic increase in heart contractility was sensed by a microaccelerometer located at the tip of a right ventricular pacing electrode. When the tilt test was repeated with the pacemaker programmed in the DDDR mode, high rate dual chamber pacing occurred during the tilt phase and prevented the syncope. Three months after implantation, the patient remains totally symptom free.
机译:在一个患有频繁晕厥的41岁男子中,倾斜测试可重复地诱发原发性血管压迫性神经心源性晕厥。药物治疗要么不能防止在倾斜试验中引起的晕厥,要么耐受性差。在晕厥之前的几分钟内,位于右心室起搏电极尖端的微加速度计检测到心脏收缩力显着增加。当使用在DDDR模式下编程的起搏器重复进行倾斜测试时,在倾斜阶段会发生高速率的双腔起搏,从而避免了晕厥。植入后三个月,患者完全没有症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号